Sherman Jeffrey W

Sherman Jeffrey W is listed in filings as Director at Larimar Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity and sale activity. Recent filings connect the profile to Larimar Therapeutics, Inc. (LRMR) and Xeris Biopharma Holdings, Inc. (XERS). The current snapshot covers public activity from May 14, 2025 to May 20, 2026. Reported amounts are shown as $183.7K to $334.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.